The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease.
Ahmed Yahia ElmowafyMohamed Hamed AbbasAhmed Abdelfattah DenewarMohamed Elsayed MashalyGamal ShihaSalwa Mahmoud El WasifLionel RostaingMohamed Adel BakrPublished in: International urology and nephrology (2020)
Hemoglobin levels of < 10.5 g/dL prior to DAA treatment did not affect the virological response in renal patients but was associated with increased serum creatinine among KTx and those with CKD.